These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

918 related items for PubMed ID: 22155902

  • 1. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
    Low JS, Wu KX, Chen KC, Ng MM, Chu JJ.
    Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
    [Abstract] [Full Text] [Related]

  • 2. Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus.
    Soto-Acosta R, Bautista-Carbajal P, Syed GH, Siddiqui A, Del Angel RM.
    Antiviral Res; 2014 Sep; 109():132-40. PubMed ID: 25017471
    [Abstract] [Full Text] [Related]

  • 3. Identification of a small-molecule inhibitor of dengue virus using a replicon system.
    Hsu YC, Chen NC, Chen PC, Wang CC, Cheng WC, Wu HN.
    Arch Virol; 2012 Apr; 157(4):681-8. PubMed ID: 22249364
    [Abstract] [Full Text] [Related]

  • 4. Primary human endothelial cells support direct but not antibody-dependent enhancement of dengue viral infection.
    Arévalo MT, Simpson-Haidaris PJ, Kou Z, Schlesinger JJ, Jin X.
    J Med Virol; 2009 Mar; 81(3):519-28. PubMed ID: 19152413
    [Abstract] [Full Text] [Related]

  • 5. Peptide inhibitors against dengue virus infection.
    Panya A, Bangphoomi K, Choowongkomon K, Yenchitsomanus PT.
    Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
    [Abstract] [Full Text] [Related]

  • 6. 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
    De Burghgraeve T, Selisko B, Kaptein S, Chatelain G, Leyssen P, Debing Y, Jacobs M, Van Aerschot A, Canard B, Neyts J.
    Antiviral Res; 2013 May; 98(2):242-7. PubMed ID: 23470860
    [Abstract] [Full Text] [Related]

  • 7. Antiviral activity of four types of bioflavonoid against dengue virus type-2.
    Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MR, Abubakar S.
    Virol J; 2011 Dec 28; 8():560. PubMed ID: 22201648
    [Abstract] [Full Text] [Related]

  • 8. Development and characterization of a stable luciferase dengue virus for high-throughput screening.
    Zou G, Xu HY, Qing M, Wang QY, Shi PY.
    Antiviral Res; 2011 Jul 28; 91(1):11-9. PubMed ID: 21575658
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication.
    van Cleef KW, Overheul GJ, Thomassen MC, Kaptein SJ, Davidson AD, Jacobs M, Neyts J, van Kuppeveld FJ, van Rij RP.
    Antiviral Res; 2013 Aug 28; 99(2):165-71. PubMed ID: 23735301
    [Abstract] [Full Text] [Related]

  • 11. Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus.
    Yang CC, Tsai MH, Hu HS, Pu SY, Wu RH, Wu SH, Lin HM, Song JS, Chao YS, Yueh A.
    Antiviral Res; 2013 May 28; 98(2):228-41. PubMed ID: 23499649
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Infection of Aedes albopictus Mosquito C6/36 Cells with the wMelpop Strain of Wolbachia Modulates Dengue Virus-Induced Host Cellular Transcripts and Induces Critical Sequence Alterations in the Dengue Viral Genome.
    Teramoto T, Huang X, Armbruster PA, Padmanabhan R.
    J Virol; 2019 Aug 01; 93(15):. PubMed ID: 31092581
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression.
    Kaur P, Thiruchelvan M, Lee RC, Chen H, Chen KC, Ng ML, Chu JJ.
    Antimicrob Agents Chemother; 2013 Jan 01; 57(1):155-67. PubMed ID: 23275491
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Identification of Compound-B, a novel anti-dengue virus agent targeting the non-structural protein 4A.
    Nobori H, Toba S, Yoshida R, Hall WW, Orba Y, Sawa H, Sato A.
    Antiviral Res; 2018 Jul 01; 155():60-66. PubMed ID: 29758236
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro inhibition of dengue virus entry by p-sulfoxy-cinnamic acid and structurally related combinatorial chemistries.
    Rees CR, Costin JM, Fink RC, McMichael M, Fontaine KA, Isern S, Michael SF.
    Antiviral Res; 2008 Nov 01; 80(2):135-42. PubMed ID: 18606464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.